Trial intelligence / Profile preview

Phase 3 trial of oral MGV-5 + AS-4370 as pretreatment for barium enema X‑ray

jRCT2080220422Phase 3

Sponsor
Ajinomoto
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium citrate and mosapride, sponsored by Ajinomoto.

02

Drugs

magnesium citratemosapride

Beyond the preview

Go deeper on jRCT2080220422.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220422.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call